Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amygdala Neurosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Amygdala Neurosciences

Amygdala Neurosciences

Amygdala Neurosciences Inc: A California-based biopharmaceutical company.

HQ
Palo Alto, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Amygdala Neurosciences Inc. is a biopharmaceutical company based in Palo Alto, California. The company's core mission is to invent and develop first-in-class medicines to treat substance use disorders (SUD). Their primary focus is on the discovery and development of ALDH2 inhibitors to help patients overcome cravings and compulsive drug-seeking behaviors associated with addiction.

Amygdala Neurosciences has made significant strides in the field of addiction treatment, positioning itself as a leader in the development of innovative therapies. By targeting the underlying mechanisms of addiction, the company aims to provide effective solutions for a condition that affects millions globally.

Amygdala Neurosciences - Similar Companies

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

Adrx logo

Adrx

adrxpharma.com

Neurotype logo

Neurotype

Alto Neuroscience logo

Alto Neuroscience

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Neuraly logo

Neuraly

neuralymed.com

Intellect Neurosciences logo

Intellect Neurosciences

Aldea Pharmaceuticals logo

Aldea Pharmaceuticals

Alzheon logo

Alzheon

alzheon.com

Cajal Neuroscience logo

Cajal Neuroscience

cajalneuro.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Neuronascent logo

Neuronascent

neuronascent.com

Amydis logo

Amydis

amydis.com

Psylin Neurosciences logo

Psylin Neurosciences

TNeuroPharma logo

TNeuroPharma

tneuropharma.com

Amygdala Neurosciences - Quick Facts

Who are Amygdala Neurosciences' competitors?

Companies similar to Amygdala Neurosciences include Embera Neurotherapeutics, Adrx, Neurotype and Alto Neuroscience.

When was Amygdala Neurosciences founded?

Amygdala Neurosciences was founded in 2015.

Where is Amygdala Neurosciences' headquarters located?

Amygdala Neurosciences' headquarters is located in Palo Alto, CA, US.

When was Amygdala Neurosciences' last funding round?

Amygdala Neurosciences' most recent funding round was for $2M (USD) in August 2023.

How much has Amygdala Neurosciences raised to-date?

As of Aug 1, 2023, Amygdala Neurosciences has raised a total of $8.9M (USD).

How many employees does Amygdala Neurosciences have?

Amygdala Neurosciences has 30 employees as of Feb 5, 2024.

Amygdala Neurosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 8000Health Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified